Probiotics are used in the prophylaxis and treatment of several conditions, including irritable bowel syndrome, diarrhoea, necrotising enterocolitis (NEC) and colic in infants. Despite the long history of probiotic use in humans, there is still significant debate about their efficacy and safety, particularly in HIV-infected and immunocompromised individuals. Here, we reviewed the safety and adverse event (AE) reporting from clinical trials that have tested probiotics in at risk populations, including HIV-infected individuals, the terminally ill and elderly, and neonates. Our analysis suggests that the benefits of probiotic therapy outweigh their potential risks in HIV-infected populations, and in the treatment of colic and NEC in low birth weight or premature neonates. Most case reports of severe AEs were in the elderly and terminally ill, or in those with additional severe medical conditions. We conclude that probiotic use, as adjunctive treatment, is effective and safe in the majority of patients including HIV-infected individuals, although special care should be taken in individuals with extreme immunosuppression and severe medical conditions in all ages.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
Anukam, K.C., Osazuwa, E.O., Osadolor, H.B., Bruce, A.W., Reid, G. and Mba, J., 2008. Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. Journal of Clinical Gastroenterology 42: 239-243.
'Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients ' () 42 Journal of Clinical GastroenterologyJournal of Clinical Gastroenterology : 239 -243.
Bengmark, S. and Jeppsson, B., 1995. Gastrointestinal surface protection and mucosa reconditioning. Journal of Parenteral and Enteral Nutrition 19: 410-415.
'Gastrointestinal surface protection and mucosa reconditioning ' () 19 Journal of Parenteral and Enteral Nutrition : 410 -415.
Bermudez-Brito, M., Plaza-DÃaz, J., Muñoz-Quezada, S., Gómez-Llorente, C. and Gil, A., 2012. Probiotic mechanisms of action. Annals of Nutrition and Metabolism 61: 160-174.
'Probiotic mechanisms of action ' () 61 Annals of Nutrition and Metabolism : 160 -174.
Bertelli, C., Pillonel, T., Torregrossa, A., Prodâhom, G., Fischer, C.J., Greub, G. and Giannoni, E., 2015. Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clinical Infectious Diseases 60: 924-927.
'Bifidobacterium longum bacteremia in preterm infants receiving probiotics ' () 60 Clinical Infectious Diseases : 924 -927.
Brenchley, J.M., Price, D.A., Schacker, T.W., Asher, T.E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., Blazar, B.R., Rodriguez, B., Teixeira-Johnson, L., Landay, A., Martin, J.N., Hecht, F.M., Picker, L.J., Lederman, M.M., Deeks, S.G. and Douek, D.C., 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Medicine 12: 1365-1371.
'Microbial translocation is a cause of systemic immune activation in chronic HIV infection ' () 12 Nature Medicine : 1365 -1371.
Brenchley, J.M., Schacker, T.W., Ruff, L.E., Price, D.A., Taylor, J.H., Beilman, G.J., Nguyen, P.L., Khoruts, A., Larson, M., Haase, A.T. and Douek, D.C., 2004. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal trace. Journal of Experimental Medicine 200: 749-759.
'CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal trace ' () 200 Journal of Experimental Medicine : 749 -759.
Chau, K., Lau, E., Greenberg, S., Jacobson, S., Yazdani-Brojeni, P., Verma, N. and Koren, G., 2015. Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938. Journal of Pediatrics 166: 74-78.
'Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938 ' () 166 Journal of Pediatrics : 74 -78.
Cherifi, S., Robberecht, J. and Miendje, Y., 2004. Saccharomyces cerevisiae fungemia in an elderly patient with Clostridum difficile colitis. Acta Clinica Belgica 59: 223-224.
'Saccharomyces cerevisiae fungemia in an elderly patient with Clostridum difficile colitis ' () 59 Acta Clinica Belgica : 223 -224.
dâEttorre, G., Ceccarelli, G., Giustini, N., Serafino, S., Calantone, N., De Girolamo, G., Bianchi, L., Bellelli, V., Ascoli-Bartoli, T., Marcellini, S., Turriziani, O., Brenchley, J.M. and Vullo, V., 2015. Probiotics reduce inflammation in antiretroviral treated, HIV-infected individuals: results of the âProbio-HIVâ clinical trial. PLoS ONE 10: e0137200.
'Probiotics reduce inflammation in antiretroviral treated, HIV-infected individuals: results of the âProbio-HIVâ clinical trial ' () 10 PLoS ONE : e0137200.
De Groote, M.A., Frank, D.N., Dowell, E., Glode, M.P. and Pace, N.R., 2005. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatric Infectious Disease Journal 24: 278-280.
'Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome ' () 24 Pediatric Infectious Disease Journal : 278 -280.
Dinh, D.M., Volpe, G.E., Duffalo, C., Bhalchandra, S., Tai, A.K., Kane, A.V., Wanke, C.A. and Ward, H.D., 2015. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. Journal of Infectious Diseases 211: 19-27.
'Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection ' () 211 Journal of Infectious Diseases : 19 -27.
Dubois, N.E. and Gregory, K.E., 2016. Characterizing the intestinal microbiome in infantile colic: findings based on an integrative review of the literature. Biological Research for Nursing 18: 307-315.
'Characterizing the intestinal microbiome in infantile colic: findings based on an integrative review of the literature ' () 18 Biological Research for Nursing : 307 -315.
Falasca, K., Vecchiet, J., Ucciferri, C., Di Nicola, M., Angelo, C.D. and Reale, M., 2015. Effect of probiotic supplement on cytokine levels in HIV-infected individuals: a preliminary study. Nutrients 7: 8335-8347.
'Effect of probiotic supplement on cytokine levels in HIV-infected individuals: a preliminary study ' () 7 Nutrients : 8335 -8347.
Fayol-Messaoudi, D., Berger, C.N., Coconnier-Polter, M.-H., Lievin-Le Moal, V. and Servin, A.L., 2005. pH-, lactic acid-, and non-lactic acid-dependent activities of probiotic lactobacilli against Salmonella enterica serovar Typhimurium. Applied and Environmental Microbiology 71: 6008-6013.
'pH-, lactic acid-, and non-lactic acid-dependent activities of probiotic lactobacilli against Salmonella enterica serovar Typhimurium ' () 71 Applied and Environmental Microbiology : 6008 -6013.
Gill, H.S., Rutherfurd, K.J., Prasad, J. and Gopal, P.K., 2000. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). British Journal of Nutrition 83: 167-176.
'Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) ' () 83 British Journal of Nutrition : 167 -176.
González-Hernández, L.A., Jave-Suarez, L.F., Fafutis-Morris, M., Montes-Salcedo, K.E., Valle-Gutierrez, L.G., Campos-Loza, A.E., Enciso-Gómez, L.F. and Andrade-Villanueva, J.F., 2012. Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial. Nutrition Journal 11: 90.
'Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial ' () 11 Nutrition Journal : 90.
Hemsworth, J.C., Hekmat, S., Reid, G., Caitlin, J., Hekmat, S. and Reid, G., 2012. Micronutrient supplemented probiotic yogurt for HIV-infected adults taking HAART in London, Canada. Micronutrient supplemented probiotic yogurt for HIV-infected adults taking HAART in London, Canada. Gut Microbes 3: 414-419.
'Micronutrient supplemented probiotic yogurt for HIV-infected adults taking HAART in London, Canada ' () 3 Gut Microbes : 414 -419.
Hummelen, R., Changalucha, J., Butamanya, N.L., Cook, A., Habbema, J.D.F. and Reid, G., 2010. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV. International Journal of Gynecology and Obstetrics 111: 245-248.
'Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV ' () 111 International Journal of Gynecology and Obstetrics : 245 -248.
Hummelen, R., Changalucha, J., Butamanya, N.L., Koyama, T.E., Cook, A., Habbema, J.D.F. and Reid, G., 2011a. Effect of 25 weeks probiotic supplementation on immune function of HIV patients. Gut Microbes 2: 80-85.
'Effect of 25 weeks probiotic supplementation on immune function of HIV patients ' () 2 Gut Microbes : 80 -85.
Hummelen, R., Hemsworth, J., Changalucha, J., Butamanya, N.L., Hekmat, S., Habbema, J.D.F. and Reid, G., 2011b. Effect of micronutrient and probiotic fortified yogurt on immune-function of anti-retroviral therapy naive HIV patients. Nutrients 3: 897-909.
'Effect of micronutrient and probiotic fortified yogurt on immune-function of anti-retroviral therapy naive HIV patients ' () 3 Nutrients : 897 -909.
Iniesta, M., Herrera, D., Montero, E., Zurbriggen, M., Matos, A.R., MarÃn, M.J., Sánchez-Beltrán, M.C., Llama-Palacio, A. and Sanz, M., 2012. Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial. Journal of Clinical Periodontology 39: 736-744.
'Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis ' () 39 Journal of Clinical Periodontology : 736 -744.
Irvine, S.L., Hummelen, R., Hekmat, S., Looman, C.W.N., Habbema, J.D.F. and Reid, G., 2010. Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS. Journal of Clinical Gastroenterology 44: 201-205.
'Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS ' () 44 Journal of Clinical Gastroenterology : 201 -205.
Jenke, A., Ruf, E., Hoppe, T., Heldmann, M. and Wirth, S., 2011. Bifidobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy. Archives of Disease in Childhood. Fetal and Neonatal Edition 97: F217-218.
'Bifidobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy ' () 97 Fetal and Neonatal Edition : F217 -218.
Kadooka, Y., Sato, M., Ogawa, A., Miyoshi, M., Uenishi, H., Ogawa, H., Ikuyama, K., Kagoshima, M. and Tsuchida, T., 2013. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. British Journal of Nutrition 110: 1696-1703.
'Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial ' () 110 British Journal of Nutrition : 1696 -1703.
Kunz, A.N., Noel, J.M. and Fairchok, M.P., 2004. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. Journal of Pediatric Gastroenterology and Nutrition 38: 457-458.
'Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome ' () 38 Journal of Pediatric Gastroenterology and Nutrition : 457 -458.
Land, M.H., Rouster-Stevens, K., Woods, C.R., Cannon, M.L., Cnota, J. and Shetty, A.K., 2005. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115: 178-181.
'Lactobacillus sepsis associated with probiotic therapy ' () 115 Pediatrics : 178 -181.
LeDoux, D., Labombardi, V.J. and Karter, D., 2006. Lactobacillus acidophilus bacteraemia after use of a probiotic in a patient with AIDS and Hodgkinâs disease. International Journal of STD and AIDS 17: 280-282.
'Lactobacillus acidophilus bacteraemia after use of a probiotic in a patient with AIDS and Hodgkinâs disease ' () 17 International Journal of STD and AIDS : 280 -282.
Li, J., Zhang, W., Wang, C., Yu, Q., Dai, R. and Pei, X., 2012. Lactococcus lactis expressing food-grade β-galactosidase alleviates lactose intolerance symptoms in post-weaning Balb/c mice. Applied Microbiology and Biotechnology 96: 1499-1506.
'Lactococcus lactis expressing food-grade β-galactosidase alleviates lactose intolerance symptoms in post-weaning Balb/c mice ' () 96 Applied Microbiology and Biotechnology : 1499 -1506.
Link-Amster, H., Rochar, F., Saudan, K.Y., Mignot, O. and Aesvhlimann, J.M., 1994. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunology and Medical Microbiology 10: 55-64.
'Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake ' () 10 FEMS Immunology and Medical Microbiology : 55 -64.
Lozupone, C.A., Li, M., Campbell, T.B., Flores, S.C., Linderman, D., Gebert, M.J., Knight, R., Fontenot, A.P. and Palmer, B.E., 2013. Alterations in the gut microbiota associated with HIV-1 infection. Cell Host and Microbe 14: 329-339.
'Alterations in the gut microbiota associated with HIV-1 infection ' () 14 Cell Host and Microbe : 329 -339.
Mai, V., Young, C.M., Ukhanova, M., Wang, X., Sun, Y., Theriaque, D., Li, N., Sharma, R., Hudak, M. and Neu, J., 2011. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS ONE 6: e20647.
'Fecal microbiota in premature infants prior to necrotizing enterocolitis ' () 6 PLoS ONE : e20647.
Makaryus, A.N., Yang, R., Hahn, R.T. and Kort, S., 2005. A rare case of Lactobacillus acidophilus presenting as mitral valve bacterial endocarditis. Echocardiography 22: 421-425.
'A rare case of Lactobacillus acidophilus presenting as mitral valve bacterial endocarditis ' () 22 Echocardiography : 421 -425.
Marseglia, G.L., Cirillo, I., Licari, A., Leone, M., Castellazzi, A.M. and Ciprandi, G., 2007. Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children : a pilot study. Therapeutics and Clinical Risk Management 3: 13-17.
'Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children : a pilot study ' () 3 Therapeutics and Clinical Risk Management : 13 -17.
Nylund, L., Satokari, R., Nikkilä, J., Rajili, M., Kalliomäki, M., Isolauri, E., Salminen, S. and De Vos, W.M., 2013. Microarray analysis reveals marked intestinal microbiota aberrancy in infants having eczema compared to healthy children in at-risk for atopic disease. BMC Microbiology 13: 12.
'Microarray analysis reveals marked intestinal microbiota aberrancy in infants having eczema compared to healthy children in at-risk for atopic disease ' () 13 BMC Microbiology : 12.
Ohishi, A., Takahashi, S., Ito, Y., Ohishi, Y., Tsukamoto, K., Nanba, Y., Ito, N., Kakiuchi, S., Saitoh, A., Morotomi, M. and Nakamura, T., 2010. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. Journal of Pediatrics Mosby 156: 679-681.
'Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele ' () 156 Journal of Pediatrics Mosby : 679 -681.
Olsen, R., Schrøder, M. and Brok, J., 2016. Prophylactic probiotics for preterm infants: a systematic review and meta-analysis of observational studies. Neonatology 109: 105-112.
'Prophylactic probiotics for preterm infants: a systematic review and meta-analysis of observational studies ' () 109 Neonatology : 105 -112.
Pridmore, R.D., Praplan, F. and Cavadini, C., 2008. Hydrogen peroxide production by Lactobacillus johnsonii NCC 533 and its role in anti-Salmonella activity. FEMS Microbiology Letters 283: 210-215.
'Hydrogen peroxide production by Lactobacillus johnsonii NCC 533 and its role in anti-Salmonella activity ' () 283 FEMS Microbiology Letters : 210 -215.
Riquelme, A.J., Calvo, M.A., Guzma, A.M., Depix, S., Garcı, P., Pe, C., Arrese, M. and Labarca, J.A., 2003. Saccharomyces cerevisiae fungemia after Saccaromyces boulardii treatment in immunocompromised patients. Journal of Clinical Gastroenterology 36: 41-43.
'Saccharomyces cerevisiae fungemia after Saccaromyces boulardii treatment in immunocompromised patients ' () 36 Journal of Clinical Gastroenterology : 41 -43.
Rosander, A., Connolly, E. and Roos, S., 2008. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Applied and Environmental Microbiology 74: 6032-6040.
'Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938 ' () 74 Applied and Environmental Microbiology : 6032 -6040.
Rossi, M., Amaretti, A. and Raimondi, S., 2011. Folate production by probiotic bacteria. Nutrients 3: 118-134.
'Folate production by probiotic bacteria ' () 3 Nutrients : 118 -134.
Salminen, M.K., Tynkkynen, S., Rautelin, H., Poussa, T., Saxelin, M., Ristola, M., Valtonen, V. and Järvinen, A., 2004. The efficacy and safety of probiotic Lactobacillus rhamnosus GG on prolonged, noninfectious diarrhea in HIV patients on antiretroviral therapy: a randomized, placebo-controlled, crossover study. HIV Clinical Trials 5: 183-191.
'The efficacy and safety of probiotic Lactobacillus rhamnosus GG on prolonged, noninfectious diarrhea in HIV patients on antiretroviral therapy: a randomized, placebo-controlled, crossover study ' () 5 HIV Clinical Trials : 183 -191.
Salminen, M.K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Sarna, S., Valtonen, V. and Jarvinen, A., 2002. Lactobacillus Bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clinical Infectious Diseases 35: 1155-1160.
'Lactobacillus Bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland ' () 35 Clinical Infectious Diseases : 1155 -1160.
Sanders, M.E., Merenstein, D.J., Ouwehand, A.C., Reid, G., Salminen, S., Cabana, M.D., Paraskevakos, G. and Leyer, G., 2016. Probiotic use in at-risk populations. Journal of the American Pharmacists Association 56: 680-686.
'Probiotic use in at-risk populations ' () 56 Journal of the American Pharmacists Association : 680 -686.
Savino, F., Cordisco, L., Tarasco, V., Palumeri, E., Calabrese, R., Oggero, R. and Matteuzzi, D., 2010. Lactobacillus reuteri DSM 17938 in infantile colic: A. Pediatrics 433: e526-e533.
'Lactobacillus reuteri DSM 17938 in infantile colic: A ' () 433 Pediatrics : e526 -e533.
Sawh, S.C., Deshpande, S., Jansen, S., Reynaert, C.J. and Jones, P.M., 2016. Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis. PeerJ 4: e2429.
'Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis ' () 4 PeerJ : e2429.
Soleman, N., Laferl, H., Kneifel, W., Tucek, G., Budschedl, E., Weber, H., Pichler, H. and Mayer, H.K., 2003. How safe is safe? A case of Lactobacillus paracasei ssp. paracasei Endocarditis and discussion of the safety of lactic acid bacteria. Scandinavian Journal of Infectious Diseases 35: 759-762.
'How safe is safe? ' () 35 Scandinavian Journal of Infectious Diseases : 759 -762.
Stratiki, Z., Costalos, C., Sevastiadou, S., Kastanidou, O., Skouroliakou, M., Giakoumatou, A. and Petrohilou, V., 2007. The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Human Development 83: 575-579.
'The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants ' () 83 Early Human Development : 575 -579.
Szajewska, H. and Dryl, R., 2016. Probiotics for the management of infantile colic. of Pediatric Gastroenterology and Nutrition 63 Suppl 1: S22-S24.
'Probiotics for the management of infantile colic ' () 63 of Pediatric Gastroenterology and Nutrition : S22 -S24.
Taylor, S.N., Basile, L.A., Ebeling, M., Wagner, C.L. and Al, T.E.T., 2009. Intestinal permeability in preterm infants by feeding type : motherâs milk versus formula. Breastfeeding Medicine 4: 11-15.
'Intestinal permeability in preterm infants by feeding type : motherâs milk versus formula ' () 4 Breastfeeding Medicine : 11 -15.
Trois, L., Cardoso, E.M. and Miura, E., 2007. Use of probiotics in HIV-infected children: a randomized double-blind controlled study. Oxford Journals 54(1): 19-24.
'Use of probiotics in HIV-infected children: a randomized double-blind controlled study ' () 54 Oxford Journals : 19 -24.
Villar-GarcÃa, J., Hernández, J.J., Güerri-Fernández, R., González, A., Lerma, E., Guelar, A., Saenz, D., SorlÃ, L., Montero, M., Horcajada, J.P. and Freud, H.K., 2015. Effect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trial. Journal of Acquired Immune Deficiency Syndromes 68: 256-263.
'Effect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trial ' () 68 Journal of Acquired Immune Deficiency Syndromes : 256 -263.
Wang, Y., Hoenig, J.D., Malin, K.J., Qamar, S., Petrof, E.O., Sun, J., Antonopoulos, D.A., Chang, E.B. and Claud, E.C., 2009. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME Journal 3: 944-954.
'16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis ' () 3 ISME Journal : 944 -954.
Wolf, B.W., Wheeler, K.B., Ataya, D.G. and Garleb, K.A., 1998. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food and Chemical Toxicology 36: 1085-1094.
'Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus ' () 36 Food and Chemical Toxicology : 1085 -1094.
Yang, O.O., Kelesidis, T. and Cordova, R., 2014. Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial. Aids Research and Human Retroviruses 30: 988-995.
'Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial ' () 30 Aids Research and Human Retroviruses : 988 -995.
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 708 | 185 | 6 |
| å ¨ææµè§æ¬¡æ° | 17 | 2 | 0 |
| PDFä¸è½½æ¬¡æ° | 15 | 0 | 0 |
Probiotics are used in the prophylaxis and treatment of several conditions, including irritable bowel syndrome, diarrhoea, necrotising enterocolitis (NEC) and colic in infants. Despite the long history of probiotic use in humans, there is still significant debate about their efficacy and safety, particularly in HIV-infected and immunocompromised individuals. Here, we reviewed the safety and adverse event (AE) reporting from clinical trials that have tested probiotics in at risk populations, including HIV-infected individuals, the terminally ill and elderly, and neonates. Our analysis suggests that the benefits of probiotic therapy outweigh their potential risks in HIV-infected populations, and in the treatment of colic and NEC in low birth weight or premature neonates. Most case reports of severe AEs were in the elderly and terminally ill, or in those with additional severe medical conditions. We conclude that probiotic use, as adjunctive treatment, is effective and safe in the majority of patients including HIV-infected individuals, although special care should be taken in individuals with extreme immunosuppression and severe medical conditions in all ages.
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 708 | 185 | 6 |
| å ¨ææµè§æ¬¡æ° | 17 | 2 | 0 |
| PDFä¸è½½æ¬¡æ° | 15 | 0 | 0 |